These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23412907)

  • 1. Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.
    Khurana A; Jung-Beom D; He X; Kim SH; Busby RC; Lorenzon L; Villa M; Baldi A; Molina J; Goetz MP; Shridhar V
    Clin Exp Metastasis; 2013 Apr; 30(4):407-15. PubMed ID: 23412907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo.
    Khurana A; McKean H; Kim H; Kim SH; mcguire J; Roberts LR; Goetz MP; Shridhar V
    Breast Cancer Res; 2012 Mar; 14(2):R43. PubMed ID: 22410125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras suppressor-1 promotes apoptosis in breast cancer cells by inhibiting PINCH-1 and activating p53-upregulated-modulator of apoptosis (PUMA); verification from metastatic breast cancer human samples.
    Giotopoulou N; Valiakou V; Papanikolaou V; Dubos S; Athanassiou E; Tsezou A; Zacharia LC; Gkretsi V
    Clin Exp Metastasis; 2015 Mar; 32(3):255-65. PubMed ID: 25647720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis.
    Borges S; Döppler H; Perez EA; Andorfer CA; Sun Z; Anastasiadis PZ; Thompson E; Geiger XJ; Storz P
    Breast Cancer Res; 2013 Aug; 15(2):R66. PubMed ID: 23971832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cadherin-11 in poor prognosis malignancies and rheumatoid arthritis: common target, common therapies.
    Assefnia S; Dakshanamurthy S; Guidry Auvil JM; Hampel C; Anastasiadis PZ; Kallakury B; Uren A; Foley DW; Brown ML; Shapiro L; Brenner M; Haigh D; Byers SW
    Oncotarget; 2014 Mar; 5(6):1458-74. PubMed ID: 24681547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts.
    Peterson SM; Iskenderian A; Cook L; Romashko A; Tobin K; Jones M; Norton A; Gómez-Yafal A; Heartlein MW; Concino MF; Liaw L; Martini PG
    BMC Cancer; 2010 Aug; 10():427. PubMed ID: 20707913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
    Yin Y; Sanders AJ; Jiang WG
    Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.
    Lemjabbar-Alaoui H; van Zante A; Singer MS; Xue Q; Wang YQ; Tsay D; He B; Jablons DM; Rosen SD
    Oncogene; 2010 Feb; 29(5):635-46. PubMed ID: 19855436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
    Chen C; Zhou Z; Sheehan CE; Slodkowska E; Sheehan CB; Boguniewicz A; Ross JS
    Int J Cancer; 2009 Jun; 124(12):2829-36. PubMed ID: 19267401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer.
    Narita K; Chien J; Mullany SA; Staub J; Qian X; Lingle WL; Shridhar V
    J Biol Chem; 2007 May; 282(19):14413-20. PubMed ID: 17363371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.
    Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schörg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA
    Cancer Res; 2013 Sep; 73(18):5810-20. PubMed ID: 23928995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer.
    Morimoto-Tomita M; Uchimura K; Bistrup A; Lum DH; Egeblad M; Boudreau N; Werb Z; Rosen SD
    Neoplasia; 2005 Nov; 7(11):1001-10. PubMed ID: 16331886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.
    Kumagai S; Ishibashi K; Kataoka M; Oguro T; Kiko Y; Yanagida T; Aikawa K; Kojima Y
    Cancer Sci; 2016 Nov; 107(11):1632-1641. PubMed ID: 27589337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.
    Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S
    Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of sulfatase-1 decreases metastatic potential of SKOV3 human ovarian cancer cells
    Mahmoud SA; Mohammed MI; Mahmoud MA; Munkaila A; Yabasin IB
    J Cancer Res Ther; 2019; 15(6):1288-1295. PubMed ID: 31898662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance.
    AlHossiny M; Luo L; Frazier WR; Steiner N; Gusev Y; Kallakury B; Glasgow E; Creswell K; Madhavan S; Kumar R; Upadhyay G
    Cancer Res; 2016 Jun; 76(11):3376-86. PubMed ID: 27197181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44/cellular prion protein interact in multidrug resistant breast cancer cells and correlate with responses to neoadjuvant chemotherapy in breast cancer patients.
    Cheng Y; Tao L; Xu J; Li Q; Yu J; Jin Y; Chen Q; Xu Z; Zou Q; Liu X
    Mol Carcinog; 2014 Sep; 53(9):686-97. PubMed ID: 23681900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
    Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
    Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.
    Lamanna WC; Frese MA; Balleininger M; Dierks T
    J Biol Chem; 2008 Oct; 283(41):27724-27735. PubMed ID: 18687675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.